Despite the above limitations, this study is the first to report STXBP5-AS1 prognostic value in COAD, and to fully investigate the molecular mechanisms and targeted drugs of STXBP5-AS1 in COAD by using the whole genome RNA sequencing dataset. This evidence concerns the gene STXBP5 and colon adenocarcinoma.